Direct oral anticoagulant secondary prophylaxis vs Low molecular weight heparin secondary prophylaxis
Minor lower GI bleeding · patients with cancer with venous thromboembolism
Direct oral anticoagulant secondary prophylaxis showed no clear difference in minor lower GI bleeding compared with low molecular weight heparin secondary prophylaxis (low certainty).
1 finding from 1 review
- Anticoagulation for the long‐term treatment of venous thromboembolism in people with cancer 2018 · Cochrane Headline outcomes onlyRR 1.54 [0.72, 3.27]2 studies · 1495 participantsLow